Effects of Dapagliflozin on Volume Status When Added to Renin–Angiotensin System Inhibitors

Sodium glucose co-transporter 2 (SGLT2) inhibitors reduce the risk of heart and kidney failure in patients with type 2 diabetes, possibly due to diuretic effects. Previous non-placebo-controlled studies with SGLT2 inhibitors observed changes in volume markers in healthy individuals and in patients w...

Descripción completa

Detalles Bibliográficos
Autores principales: Eickhoff, Mie K., Dekkers, Claire C. J., Kramers, Bart J., Laverman, Gozewijn Dirk, Frimodt-Møller, Marie, Jørgensen, Niklas Rye, Faber, Jens, Danser, A. H. Jan, Gansevoort, Ron T., Rossing, Peter, Persson, Frederik, Heerspink, Hiddo J. L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6616433/
https://www.ncbi.nlm.nih.gov/pubmed/31159350
http://dx.doi.org/10.3390/jcm8060779

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6616433/
https://www.ncbi.nlm.nih.gov/pubmed/31159350
http://dx.doi.org/10.3390/jcm8060779

Ejemplares similares